GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Kedudukan dalam Saham
#3636
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Harga Saham
$27.54
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$4.67B
Perubahan (1 hari)
-2.73%
Perubahan (1 tahun)
-11.86%
Negara
IN
Perdagangan GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategori
Healthcare
Sejarah dividen untuk GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
GlaxoSmithKline Pharmaceuticals Limited (simbol saham: GLAXO) telah membuat sejumlah 24 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): $582.25
Hasil dividen (TTM): 0.0228
Jumlah semua dividen (disesuaikan untuk pemecahan saham): $582.25
Hasil dividen (TTM): 0.0228
Pembayaran dividen untuk GlaxoSmithKline Pharmaceuticals Limited (GLAXO) dari 2003 hingga 2026
Pembayaran dividen tahunan
| Tahun | Dividen (diselaraskan untuk pemecahan saham) | Ubah |
|---|---|---|
| 2026 (TTM) | $42.00 | 0.00% |
| 2025 | $42.00 | -4.55% |
| 2024 | $44.00 | 37.50% |
| 2023 | $32.00 | -64.44% |
| 2022 | $90.00 | 200.00% |
| 2021 | $30.00 | -25.00% |
| 2020 | $40.00 | 100.00% |
| 2019 | $20.00 | 14.29% |
| 2018 | $17.50 | 16.67% |
| 2017 | $15.00 | -40.00% |
| 2016 | $25.00 | -20.00% |
| 2015 | $31.25 | 25.00% |
| 2014 | $25.00 | 0.00% |
| 2013 | $25.00 | 11.11% |
| 2012 | $22.50 | 12.50% |
| 2011 | $20.00 | 33.33% |
| 2010 | $15.00 | -25.00% |
| 2009 | $20.00 | 11.11% |
| 2008 | $18.00 | 16.13% |
| 2007 | $15.50 | 10.71% |
| 2006 | $14.00 | 16.67% |
| 2005 | $12.00 | 140.00% |
| 2004 | $5.00 | 42.86% |
| 2003 | $3.50 | 0.00% |
Senarai semua pembayaran dividen
| Tahun | Dividen | Ubah |
|---|---|---|
| 2026 (TTM) | $42.00 | 0.00% |
| 2025 | $42.00 | -4.55% |
| 2024 | $44.00 | 37.50% |
| 2023 | $32.00 | -64.44% |
| 2022 | $90.00 | 200.00% |
| 2021 | $30.00 | -25.00% |
| 2020 | $40.00 | 100.00% |
| 2019 | $20.00 | -42.86% |
| 2018 | $35.00 | 16.67% |
| 2017 | $30.00 | -40.00% |
| 2016 | $50.00 | -20.00% |
| 2015 | $62.50 | 25.00% |
| 2014 | $50.00 | 0.00% |
| 2013 | $50.00 | 11.11% |
| 2012 | $45.00 | 12.50% |
| 2011 | $40.00 | 33.33% |
| 2010 | $30.00 | -25.00% |
| 2009 | $40.00 | 11.11% |
| 2008 | $36.00 | 16.13% |
| 2007 | $31.00 | 10.71% |
| 2006 | $28.00 | 16.67% |
| 2005 | $24.00 | 140.00% |
| 2004 | $10.00 | 42.86% |
| 2003 | $7.00 | 0.00% |
Pembayaran dividen untuk syarikat serupa atau pesaing
| Syarikat | Jumlah pembayaran dividen | Negara |
|---|---|---|
| 215.00% |
US
|
|
| 225.00% |
US
|
|
| 53.00% |
US
|
|
| 223.00% |
US
|
|
| 33.00% |
CH
|
